FJC(SH:600802)2024-10-23 08:23Financial Performance - The company's operating revenue for Q3 2024 was ¥406,071,882.08, representing a decrease of 13.33% compared to the same period last year[2]. - The net profit attributable to shareholders was -¥62,762,642.74, an increase of 33.90% year-on-year[2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥65,467,840.11, reflecting a year-on-year increase of 31.62%[2]. - The basic earnings per share for the period was -¥0.14, which is an improvement of 33.90% compared to the previous year[2]. - Total operating revenue for the first three quarters of 2024 was approximately ¥1.12 billion, a decrease of 25.2% compared to ¥1.49 billion in the same period of 2023[10]. - Net profit for the first three quarters of 2024 was approximately -¥213.38 million, an improvement from -¥293.11 million in the same period of 2023[11]. - Operating profit for the first three quarters of 2024 was approximately -¥216.14 million, an improvement from -¥293.63 million in the same period of 2023[10]. - Total profit for the first three quarters of 2024 was approximately -¥213.05 million, compared to -¥292.62 million in the same period of 2023[10]. Assets and Liabilities - The total assets at the end of the reporting period were ¥3,861,124,693.39, a slight decrease of 0.13% from the end of the previous year[2]. - The equity attributable to shareholders decreased by 7.71% to ¥1,096,572,882.68 compared to the end of the previous year[2]. - Total non-current assets decreased to CNY 3,381,356,643.64 from CNY 3,474,963,650.40, a decline of approximately 2.7%[8]. - Total liabilities increased to CNY 2,764,068,974.71 from CNY 2,632,089,073.46, representing an increase of about 5%[9]. - The company's total equity decreased to CNY 1,097,055,718.68 from CNY 1,234,090,966.44, a decline of approximately 11.1%[9]. Cash Flow - The net cash flow from operating activities for the year-to-date was -¥79,961,851.26, showing a decrease of 46.18% year-on-year[2]. - The company reported a net cash outflow from operating activities, indicating challenges in cash generation despite revenue adjustments[11]. - Net cash flow from operating activities was -79,961,851.26 CNY, an improvement from -148,559,977.65 CNY in the previous year[12]. - Cash inflow from financing activities increased to 1,523,250,000.00 CNY, compared to 979,000,000.00 CNY in the same period last year[13]. - Cash outflow from financing activities totaled 1,407,932,704.27 CNY, up from 746,130,774.42 CNY year-over-year[13]. - The net cash flow from investing activities was 14,023,620.27 CNY, a significant recovery from -40,827,927.36 CNY in the previous year[12]. - The company reported a net increase in cash and cash equivalents of 49,379,064.74 CNY, compared to 43,481,320.57 CNY in the previous year[13]. Current Assets - As of September 30, 2024, total current assets increased to CNY 479,768,049.75 from CNY 391,216,389.50 at the end of 2023, representing a growth of approximately 22.5%[8]. - The company's cash and cash equivalents rose to CNY 165,567,650.70 compared to CNY 116,364,236.86 at the end of 2023, marking an increase of about 42.3%[8]. - Accounts receivable decreased significantly to CNY 484,758.50 from CNY 11,393.62, indicating a reduction of approximately 96.8%[8]. - Inventory increased to CNY 171,695,247.58 from CNY 152,350,338.77, reflecting a growth of about 12.7%[8]. - Cash received from sales of goods and services was approximately ¥1.12 billion, a decrease of 29.0% from ¥1.57 billion in the same period of 2023[11]. Comprehensive Income - Non-recurring gains and losses totaled ¥2,705,197.37 for the current period, with a year-to-date total of ¥5,868,302.03[3]. - The company’s other comprehensive income rose to CNY 401,423,643.19 from CNY 326,916,083.44, reflecting an increase of approximately 22.7%[9]. - Other comprehensive income after tax for the first three quarters of 2024 was approximately ¥74.51 million, compared to -¥27.52 million in the same period of 2023[11]. Research and Development - Research and development expenses increased significantly to approximately ¥9.08 million, up 244.5% from ¥2.63 million in the same period of 2023[10].